These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 22050852)
21. The role of HLA-G in cytokine homeostasis during early pregnancy complicated with maternal infections: a novel etiopathological approach to the neurodevelopmental understanding of schizophrenia. Debnath M; Chaudhuri TK Med Hypotheses; 2006; 66(2):286-93. PubMed ID: 16183209 [TBL] [Abstract][Full Text] [Related]
22. Preview of immunological reviews for 2012. Koretzky G Immunol Rev; 2012 Jan; 245(1):5-6. PubMed ID: 22168409 [No Abstract] [Full Text] [Related]
23. The promise of epidemiologic studies: neuroimmune mechanisms in the etiologies of brain disorders. Ellman LM; Susser ES Neuron; 2009 Oct; 64(1):25-7. PubMed ID: 19840544 [TBL] [Abstract][Full Text] [Related]
24. [Dynamic paradigm in psychopathology: "chaos theory", from physics to psychiatry]. Pezard L; Nandrino JL Encephale; 2001; 27(3):260-8. PubMed ID: 11488256 [TBL] [Abstract][Full Text] [Related]
25. CNS signal transduction in the pathophysiology and pharmacotherapy of affective disorders and schizophrenia. Hudson CJ; Young LT; Li PP; Warsh JJ Synapse; 1993 Mar; 13(3):278-93. PubMed ID: 8497811 [TBL] [Abstract][Full Text] [Related]
26. Limbic circuits and neuropsychiatric disorders. Functional anatomy and neuroimaging findings. Byrum CE; Thompson JE; Heinz ER; Krishnan KR; Tien RD Neuroimaging Clin N Am; 1997 Feb; 7(1):79-99. PubMed ID: 9100233 [TBL] [Abstract][Full Text] [Related]
27. Neural ECM in addiction, schizophrenia, and mood disorder. Lubbers BR; Smit AB; Spijker S; van den Oever MC Prog Brain Res; 2014; 214():263-84. PubMed ID: 25410362 [TBL] [Abstract][Full Text] [Related]
28. Cannabis and psychiatric disorders: it is not only addiction. Leweke FM; Koethe D Addict Biol; 2008 Jun; 13(2):264-75. PubMed ID: 18482435 [TBL] [Abstract][Full Text] [Related]
33. For whom the endocannabinoid tolls: Modulation of innate immune function and implications for psychiatric disorders. Henry RJ; Kerr DM; Finn DP; Roche M Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jan; 64():167-80. PubMed ID: 25794989 [TBL] [Abstract][Full Text] [Related]
34. Age and neuroinflammation: a lifetime of psychoneuroimmune consequences. Godbout JP; Johnson RW Neurol Clin; 2006 Aug; 24(3):521-38. PubMed ID: 16877122 [TBL] [Abstract][Full Text] [Related]
35. Role of endogenous biological response modifiers in pathogenesis of infectious diseases. Mullangi PK; Shahani L; Koirala J Infect Dis Clin North Am; 2011 Dec; 25(4):733-54. PubMed ID: 22054753 [TBL] [Abstract][Full Text] [Related]
36. Keeping the balance between immune tolerance and pathogen immunity with endogenous neuropeptides. Gonzalez-Rey E Neuroimmunomodulation; 2010; 17(3):161-4. PubMed ID: 20134192 [TBL] [Abstract][Full Text] [Related]
37. Activation of innate immunity system during aging: NF-kB signaling is the molecular culprit of inflamm-aging. Salminen A; Huuskonen J; Ojala J; Kauppinen A; Kaarniranta K; Suuronen T Ageing Res Rev; 2008 Apr; 7(2):83-105. PubMed ID: 17964225 [TBL] [Abstract][Full Text] [Related]
38. Review of immunological and immunopathological findings in schizophrenia. Rothermundt M; Arolt V; Bayer TA Brain Behav Immun; 2001 Dec; 15(4):319-39. PubMed ID: 11782102 [TBL] [Abstract][Full Text] [Related]
39. In immune defense: redefining the role of the immune system in chronic disease. Rubinow KB; Rubinow DR Dialogues Clin Neurosci; 2017 Mar; 19(1):19-26. PubMed ID: 28566944 [TBL] [Abstract][Full Text] [Related]